tiprankstipranks
Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Holding DE:DUL?
Track your performance easily

Alnylam Pharma (DUL) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Alnylam Pharmaceuticals’s (DUL) Moving Averages Convergence Divergence (MACD) indicator is -3.53, suggesting Alnylam Pharmaceuticals is a Buy.
Alnylam Pharmaceuticals’s (DUL) 20-Day exponential moving average is 235.77, while Alnylam Pharmaceuticals’s (DUL) share price is €228.1, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) 50-Day exponential moving average is 239.99, while Alnylam Pharmaceuticals’s (DUL) share price is €228.1, making it a Sell.

Alnylam Pharma (DUL) Pivot Points

Dec 22, 2024, 07:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
225.30
226.00
227.40
228.10
229.50
230.20
231.60
Fibonacci
226.00
226.80
227.30
228.10
228.90
229.40
230.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Alnylam Pharma (DUL) Moving Averages

Dec 22, 2024, 07:40 AM
Period
Simple
Exponential
MA5
230.68Sell
230.76Sell
MA10
234.56Sell
233.01Sell
MA20
236.41Sell
235.77Sell
MA50
246.99Sell
239.99Sell
MA100
243.74Sell
234.51Sell
MA200
204.09Buy
207.50Buy
Alnylam Pharmaceuticals’s (DUL) 10-Day exponential moving average is 233.01, while Alnylam Pharmaceuticals’s (DUL) share price is €228.1, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) 100-Day exponential moving average is 234.51, while Alnylam Pharmaceuticals’s (DUL) share price is €228.1, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) stock price is €228.1 and Alnylam Pharmaceuticals’s (DUL) 50-day simple moving average is 246.99, creating a Sell signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €228.1 and Alnylam Pharmaceuticals’s (DUL) 100-day simple moving average is 243.74, creating a Sell signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €228.1 and Alnylam Pharmaceuticals’s (DUL) 200-day simple moving average is 204.09, creating a Buy signal.

Alnylam Pharma (DUL) Technical Indicators

Dec 22, 2024, 07:40 AM
Name
Value
Implied Action
RSI (14)
36.78
Neutral
STOCH (9,6)
18.34
Buy
STOCHRSI (14)
18.25
Buy
MACD (12,26)
-3.53
Buy
ADX (14)
18.23
Buy
Williams %R
-90.21
Buy
CCI (14)
-153.66
Buy
ATR (14)
2.95
-
Ultimate Oscillator
32.17
Neutral
ROC
-4.64
Sell
Alnylam Pharmaceuticals’s (DUL) Relative Strength Index (RSI) is 36.78, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Trend Strength Indicator (ADX) is 18.23, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) Commodity Channel Index (CCI) is -153.66, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) Price Rate of Change (ROC) is -4.64, creating a Sell signal.

FAQ

Is DUL a Buy, Hold, or Sell?
Based on DUL’s technical indicators, DUL is a Sell.
    What is DUL’s RSI (14)?
    DUL’s RSI (14) is 36.78, which suggests DUL is a Neutral.
      What is DUL’s MACD?
      DUL’s MACD is -3.53, which suggests DUL is a Buy.
        What is DUL’s 5-day moving average?
        DUL’s 5-day moving average is 230.68, which suggests DUL is a Sell.
          What is DUL’s 20-day moving average?
          DUL 20-day moving average is 236.41, which suggests DUL is a Sell.
            What is DUL’s 50-day moving average?
            DUL’s 50-day moving average is 246.99, which suggests DUL is a Sell.
              What is DUL’s 200-day moving average?
              DUL’s 200-day moving average is 204.09, which suggests DUL is a Buy.
                What is DUL’s Williams % R (14)?
                DUL’s Williams % R (14) is -90.21, which suggests DUL is a Buy.
                  What is DUL’s CCI (14)?
                  DUL’s CCI (14) is -153.66, which suggests DUL is a Buy.
                    What is the share price of Alnylam Pharmaceuticals?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis